These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36439571)

  • 1. Recurrence of a Rare Subtype of Guillain-Barré Syndrome Following a Second Dose of the Shingles Vaccine.
    Chohan S; Chohan A
    Cureus; 2022 Oct; 14(10):e30717. PubMed ID: 36439571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome following varicella-zoster virus infection: a case report and systematic review.
    Nerabani Y; Atli AA; Hamdan O; Hajjar Mwaffak A; Haj Hammadh NAH; Marstawi H; Hora S; Alabd N
    Ann Med Surg (Lond); 2023 Nov; 85(11):5621-5628. PubMed ID: 37915710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Analysis of Spontaneously Reported Data of Vesicular and Bullous Cutaneous Eruptions Occurring Following Vaccination with the Adjuvanted Recombinant Zoster Vaccine.
    Pirrotta P; Tavares-Da-Silva F; Co M; Lecrenier N; Hervé C; Stegmann JU
    Drug Saf; 2021 Dec; 44(12):1341-1353. PubMed ID: 34622421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome following varicella-zoster virus infection.
    Islam B; Islam Z; GeurtsvanKessel CH; Jahan I; Endtz HP; Mohammad QD; Jacobs BC
    Eur J Clin Microbiol Infect Dis; 2018 Mar; 37(3):511-518. PubMed ID: 29411189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries.
    Goud R; Lufkin B; Duffy J; Whitaker B; Wong HL; Liao J; Lo AC; Parulekar S; Agger P; Anderson SA; Wernecke M; MaCurdy TE; Weintraub E; Kelman JA; Forshee RA
    JAMA Intern Med; 2021 Dec; 181(12):1623-1630. PubMed ID: 34724025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 Vaccination a Cause of Guillain-Barré Syndrome? A Case Series.
    Nagdev G; Chavan G; Sahu G; Devasilpa Raju PD
    Cureus; 2022 Oct; 14(10):e30888. PubMed ID: 36465787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Guillain-Barré syndrome following herpes zoster, United States, 2010-2018.
    Anderson TC; Leung JW; Harpaz R; Dooling KL
    Hum Vaccin Immunother; 2021 Dec; 17(12):5304-5310. PubMed ID: 34856864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe Guillain-Barré syndrome following primary infection with varicella zoster virus in an adult.
    Cresswell F; Eadie J; Longley N; Macallan D
    Int J Infect Dis; 2010 Feb; 14(2):e161-3. PubMed ID: 19502090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.
    Arya DP; Said MA; Izurieta HS; Perez-Vilar S; Zinderman C; Wernecke M; Alexander M; White T; Su IH; Lufkin B; MaCurdy T; Kelman J; Forshee R
    Vaccine; 2019 Oct; 37(43):6543-6549. PubMed ID: 31515146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guillain-Barré syndrome following the second dose of COVID AstraZeneca vaccine in a 78-year-old male: a case report from Nepal.
    Acharya B; Kc S; Karki S; Thapa P; Kc P
    Ann Med Surg (Lond); 2023 Mar; 85(3):466-469. PubMed ID: 36923770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrent Guillain-Barré Syndrome - Case Series.
    Basta I; Bozovic I; Berisavac I; Stojiljkovic-Tamas O; Rajic SL; Dominovic-Kovacevic A; Stojanov A; Djordjevic G; Jovanovic D; Peric S
    Neurol India; 2019; 67(6):1536-1538. PubMed ID: 31857555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post Vaccination Guillain Barre Syndrome: A Case Report.
    Wajih Ullah M; Qaseem A; Amray A
    Cureus; 2018 Apr; 10(4):e2511. PubMed ID: 29930889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent Guillain-Barré Syndrome Following Urinary Tract Infection by Escherichia coli.
    Jo YS; Choi JY; Chung H; Kim Y; Na SJ
    J Korean Med Sci; 2018 Jan; 33(4):e29. PubMed ID: 29318796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demyelinating Guillain-Barré syndrome recurs more frequently than axonal subtypes.
    Notturno F; Kokubun N; Sekiguki Y; Nagashima T; De Lauretis A; Yuki N; Kuwabara S; Uncini A
    J Neurol Sci; 2016 Jun; 365():132-6. PubMed ID: 27206890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines and the risk of Guillain-Barré syndrome.
    Chen Y; Zhang J; Chu X; Xu Y; Ma F
    Eur J Epidemiol; 2020 Apr; 35(4):363-370. PubMed ID: 31858323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome following chickenpox: a case series.
    Tatarelli P; Garnero M; Del Bono V; Camera M; Schenone A; Grandis M; Benedetti L; Viscoli C
    Int J Neurosci; 2016; 126(5):478-9. PubMed ID: 26000930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome.
    Hilts A; Schreiber A; Singh A
    Am J Case Rep; 2022 Aug; 23():e936896. PubMed ID: 35945825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surveillance for Guillain-Barré syndrome after influenza vaccination among U.S. Medicare beneficiaries during the 2017-2018 season.
    Perez-Vilar S; Wernecke M; Arya D; Lo AC; Lufkin B; Hu M; Chu S; MaCurdy TE; Kelman J; Forshee RA
    Vaccine; 2019 Jun; 37(29):3856-3865. PubMed ID: 31122853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Rare Case of Guillain-Barré Syndrome Associated With SARS-CoV-2 Infection Requiring Mechanical Ventilation.
    Rane RP; Jain A; Hussain KM; Naik S; Shahab A
    Cureus; 2022 Jun; 14(6):e25810. PubMed ID: 35720780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome following influenza vaccination.
    Haber P; DeStefano F; Angulo FJ; Iskander J; Shadomy SV; Weintraub E; Chen RT
    JAMA; 2004 Nov; 292(20):2478-81. PubMed ID: 15562126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.